Anthony “Tony” Manna is President of Cochlear’s North American division, having served the company for over 16 years. In his role, he oversees the development and execution of strategy for their North American operations. During his time at the company, he has held a myriad of roles, starting in sales and working up to the President of Cochlear’s Bone Anchored Solutions. His background is in sales for various medical equipment companies, including Gyrus and Cabot Medical.

In this episode…

The industry behind medical devices can be difficult to traverse when it comes to balancing profit and health. There’s always going to be pressure on one side or the other, leading to difficult questions for companies in the field. However, cochlear implants are different from most other medical instruments. Their newer technology and important function makes them a unique product from a business perspective.

Tony Manna has learned this over the 16 years he’s spent with Cochlear of North America. He personally found the industry less cutthroat than he was anticipating, learning both the science behind and the benefits of cochlear implants. Now, he shares those takeaways with you.

Dr. Mark Syms hosts Tony Manna, the President of Cochlear’s North American division, to talk about the business and the science behind cochlear implants. The two go through the qualifications, the new software in the industry, and the greatest hurdles facing implants today. They also touch on the lingering effects of the pandemic on the business side and how it’s changed the market. Hear the rest on this episode of the ListenUp! Podcast.